Navigation Links
Hair Loss Research Study Reveals Important Breakthrough in the Treatment of Male Pattern Baldness
Date:6/1/2010

Hair loss research study shows the benefits of a novel combination of two FDA Approved topical medications. This triple blind controlled hair loss prevention study highlights a remarkable new finding.

Pleasant Valley, New York (Vocus) June 1, 2010 -- Dr. Oscar Klein M.D. today announced the results of a triple blind hair loss research study involving two FDA approved hair growth medications: Minoxidil and Finesteride.

Three groups of individuals were used in the study: Group I was the placebo group, Group II applied 5% Minoxidil lotion, Group III applied 5% Minoxidil lotion, 0.025% tretinoin (Retin A) and 0.1% Finesteride. The subjects were evaluated every six months with the help of a subjective questionnaire, objective examination and close-up photographs.

In the Placebo Group, there was neither any improvement nor deterioration. In the Minoxidil Group 25% of the subjects showed hair growth. In the Combination Group as much as 75% of the subjects showed improvement. The quality of the newly grown hair was also better in the combination group.

According to Dr. Klein, “The significance of this study cannot be over emphasized." This study serves as the basis for Dr. Klein's development of ProMox™ - one of the most exciting hair loss products available for men.

Dr Klein is known for creating unique and innovative hair growth treatments for men and women by combining real world client results with ongoing product research and development. Dr Klein offers ongoing consultations for his clients. He listens closely to their hair growth product experiences and monitors their progress.

This study may have focused on male pattern baldness, but it has implications for hair loss in women. Dr Klein created a product called ReMox™ which is a combination of 5% Monoxidil and 0.025% tretinoin (Retin A). Dr. Klein's exclusive, easily absorbed ReMox™ formula gives far superior results than competing topical remedies for up to HALF the cost.

Dr Klein is committed to helping his clients achieve their desired hair growth results and offers a no cost, private, confidential consultation in order to create an individualized treatment program.

Visit: www.HairGrowthMD.com for all the details on this study or to find out more about the benefits of Dr. Klein’s hair growth products for men and women and to schedule your free no-obligation in-person or phone consultation with Dr. Klein. US callers call: 1 800 992-2474, International callers call 1 845 723-4334.


About Dr. Oscar Klein, MD:

Dr. Oscar Klein M.D. holds degrees in medicine and psychiatry. Dr. Klein worked as a consulting psychiatrist in Tel Aviv and New York and served as an emergency physician at Putnam Community and Vassar Hospitals. Dr. Klein established the Westbay Medical Center in Florida and was the sole primary physician on staff. He established his own psychiatric practice and is credited for the Center’s management of psychopharmacology. He is also founder of http://www.HairGrowthMD.com a comprehensive site that educates men and women on hair re-growth, offers information and lists information on Dr. Klein’s breakthrough hair growth promoting products for men and women. Dr. Klein consults with clients across the country and overseas from his offices in Pleasant Valley, New York. Dr. Klein has treated tens of thousands of clients around the world who are walking testimonies to the results of his products.    

Contact:

Dr Klein MD
www.HairGrowthMD.com
DrKlein(at)HairGrowthMD(dot)com
59 Traver Road
Pleasant Valley, NY 12569
1 845 723-4334 phone
1 845 723-4339 fax

# # #

Read the full story at http://www.prweb.com/releases/hairgrowth/hairloss/prweb4067934.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. U of A discovery offers promising research for spinal-cord injury treatments
2. Research finds surgery outperforms drug therapy in treatment of benign prostatic hyperplasia
3. Researchers report no difference in breast cancer characteristics after oophorectomy
4. Vanderbilt researchers play major role in new center on electronic health information privacy
5. New research at the University of Leicester links shoplifting to your personality
6. OHSU joins forces with UO, Harvard to accelerate Fanconi anemia research
7. Pitt researchers discover gene mutation linked to lymphatic dysfunction
8. Researchers validate a new test for assessing childrens and teenagers fitness to prevent morbidity
9. Chef Charles Phillips of Nashville's 1808 Grille, Teams up with National Foundation for Cancer Research, Offering Gourmet Healthy Living Options
10. Rensselaer researcher wins $1.4 million NIH grant to enable faster cancer treatment planning
11. NIH awards $10M to Einstein for diabetes research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Nursing Society (ONS) wanted to create a communications platform that positions them as ... goal, Elliance and ONS reinvented their online publication as an always-on, always-fresh news, ...
(Date:3/24/2017)... ... March 24, 2017 , ... On ... Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She will present ... majority of cases litigated under ERISA involve claims for long-term disability benefits. ...
(Date:3/24/2017)... ... ... Viewers who like to educate themselves on current issues and who enjoy ... societal issues tend to appreciate and love the "Informed" series, hosted by Rob Lowe. ... for causes around the world. , Running for charity has become a ...
(Date:3/24/2017)... Southlake, Texas (PRWEB) , ... March 24, 2017 ... ... make 2017 the year of enhancements, upgrading their training and leads programs. , ... Empower University. Reserved for elite sales agents, Performance Partners is designed to teach ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding ... God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion with ... Walk with God #TruthwithGrace” is the creation of published author Lea Michelle Johnson, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... KNOXVILLE, Tenn. , March 23, 2017 /PRNewswire/ ... ("Provectus" or the "Company"), a clinical-stage oncology and ... previously announced Definitive Financing Commitment Term Sheet (the ... with a group of the Company,s stockholders, who ... "PRH Group" in a Form 8-K filed with ...
(Date:3/23/2017)... March 23, 2017 The key factors ... increasing diabetic population, accelerating economic growth and increasing healthcare expenditure. ... are higher life expectancy of ESRD patients, rising demand for ... However, the expansion of the market is hindered by high ... ...
(Date:3/23/2017)... -- As a result of diagnostic technology increasing ... allergic diseases, cutting edge developments in targeted drugs ... in which pharmaceutical and biotech companies are addressing ... both a high quality meeting and a platform ... research scholars and doctors. The event will also ...
Breaking Medicine Technology: